AstraZeneca to Establish R&D Center and Innovation Park in Hong Kong, Says It Will Inject New Momentum into Regional Pharmaceutical Research

According to the news from the Radio Television Hong Kong website, AstraZeneca will establish a research and development center and innovation park in Hong Kong. Paul Chan, the Financial Secretary of Hong Kong, stated that the R&D center will focus on areas such as cell therapy research, which he believes can inject new momentum into regional pharmaceutical R&D. He reiterated that Hong Kong has advantages such as free capital flow and convenient financing for the development of the life sciences and health industry.